Biotechnology company Moderna expects to earn more money from its corona vaccine this year than previously reported. The company raised its sales forecast for the vaccine in a trade update aided by the company’s efforts to ramp up production after last year’s manufacturing difficulties. Moderna expects a turnover of 19 billion dollars for the entire year, or 17 billion euros.
ttn-3
